Liferay Portal has an XXE vulnerability in Java2WsddTask._format
XXE vulnerability in Liferay Portal 7.2.0 through 7.4.3.7, and older unsupported versions, and Liferay DXP 7.4 before update 4, 7.3 before update 12, 7.2 before fix pack 20, and older unsupported versions allows attackers with permission to deploy widgets/portlets/extensions to obtain sensitive information or consume system resources via the Java2WsddTask._format method.
Affected software
Click a technology to see all vulnerabilities affecting it.
| Platform | Package | Vulnerable versions | Fixed in |
|---|---|---|---|
| Java / Kotlin (Maven) | com.liferay.portal:com.liferay.util.java | < 14.0.0 | 14.0.0 |
| Java / Kotlin (Maven) | com.liferay.portal:release.dxp.bom | >= 7.3.0, < 7.3.10.u12, >= 7.4.0, < 7.4.13.u4, < 7.2.10.fp20 | 7.3.10.u12, 7.4.13.u4, 7.2.10.fp20 |
| Java / Kotlin (Maven) | com.liferay.portal:release.portal.bom | < 7.4.3.8 | 7.4.3.8 |
References
- CVSS vector
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:C/C:H/I:H/A:H- Weakness (CWE)
CWE-611- Platform
- Java / Kotlin (Maven)
- Package
com.liferay.portal:com.liferay.util.java, com.liferay.portal:release.dxp.bom, com.liferay.portal:release.portal.bom- Disclosed
- 20.02.2024
- Updated
- 11.10.2026 12:21
Sources and licenses
OSV / GitHub Advisory Database - GHSA-869h-qhfx-w939 - CC BY 4.0
Vulnerability history: com.liferay.portal:com.liferay.util.java
All published vulnerabilities of this package (Java / Kotlin (Maven)), newest first. Shows whether this is a one-off slip or a package that needs watching.
- Total entries
- 2
- First → latest
- 09.2022 02.2024
- Without a fix
- 0
- Exploited in attacks
- 0
Severity breakdown
- High 1
- Medium 1
Disclosures per year
- 2022: 1
- 2023: 0
- 2024: 1
- 2025: 0
- 2026: 0
-
Liferay Portal has an XXE vulnerability in Java2WsddTask._format this entry
Know which vulnerabilities affect your application
With the DockRay integration and software inventory enabled, DockRay checks reported component versions against known vulnerabilities and notifies you about confirmed matches. Coverage depends on the supported technology and available advisory data.